Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,481 to 1,500 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Two Sides of the Same Coin: The Roles of KLF6 in Physiology and Pathophysiology. | Biomolecules | 2020 | 32998281 | PubTator, text mining | PubMed |
| Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia. | Cancers (Basel) | 2020 | 32992503 | PubTator, text mining | PubMed |
| Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia. | Front Oncol | 2020 | 32984037 | PubTator, text mining | PubMed |
| Uterine relapse of Philadelphia chromosome-negative acute lymphoblastic leukemia. | J Clin Exp Hematop | 2020 | 32981913 | PubTator, text mining | PubMed |
| Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway. | Cell Death Dis | 2020 | 32968054 | PubTator, text mining | PubMed |
| Long Non-Coding RNA-Ribonucleoprotein Networks in the Post-Transcriptional Control of Gene Expression. | Noncoding RNA | 2020 | 32957640 | PubTator, text mining | PubMed |
| A novel vitamin D gene therapy for acute myeloid leukemia. | Transl Oncol | 2020 | 32956997 | PubTator, text mining | PubMed |
| Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis. | Evol Bioinform Online | 2020 | 32952395 | PubTator, text mining | PubMed |
| Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin. | Mol Med Rep | 2020 | 32945422 | PubTator, text mining | PubMed |
| The Association of FLT3-ITD Gene Mutation with Bone Marrow Blast Cell Count, CD34, Cyclin D1, Bcl-xL and hENT1 Expression in Acute Myeloid Leukemia Patients. | Iran J Pathol | 2020 | 32944043 | PubTator, text mining | PubMed |
| [Intraperitoneal perfusion of gemtuzumab-ozogamicin combined with allogeneic hematopoietic stem cell transplantation in intestinal solitary myeloid sarcoma: a case report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2020 | 32942825 | PubTator, text mining | PubMed |
| IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. | Elife | 2020 | 32936072 | PubTator, text mining | PubMed |
| RNA sequencing-based identification of potential targets in acute myeloid leukemia: A case report. | Biomed Rep | 2020 | 32934815 | PubTator, text mining | PubMed |
| Down syndrome iPSC model: endothelial perspective on tumor development. | Oncotarget | 2020 | 32934781 | PubTator, text mining | PubMed |
| The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. | Int J Mol Sci | 2020 | 32932777 | PubTator, text mining | PubMed |
| An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles. | Commun Biol | 2020 | 32917965 | PubTator, text mining | PubMed |
| A Rare Case of Coexisting Breast Cancer and Refractory Acute Myeloid Leukemia. | Case Rep Hematol | 2020 | 32908731 | PubTator, text mining | PubMed |
| All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells. | Cell Cycle | 2020 | 32900260 | PubTator, text mining | PubMed |
| The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors. | Cells | 2020 | 32900001 | PubTator, text mining | PubMed |
| Natural HDAC-1/8 inhibitor baicalein exerts therapeutic effect in CBF-AML. | Clin Transl Med | 2020 | 32898337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=75